Registration Form

Welcome!

"Does your patient complain of fatigue, breathlessness, leg swelling, and neuropathy?

Is it long-COVID, Lyme disease, chronic fatigue?

Could this be AL Amyloidosis?"

Please register below to access the webinar.

Once you submit, you will be redirected to the webinar recording and evaluation to obtain CME/CNE credit.

**If you would like the recording link to be sent to you, kindly check "send me a copy of my responses" at the bottom of this form.**

First Name

Last Name

Email Address

City

State/Province

Country/Region

Phone

Occupation

Organization

(Please provide the full organization name)

Practice Setting

Professional Degree

Gender

Primary Care

Medical Specialist

Number of Years in Practice:

_________ years

Self-rating:

**Pre-Webinar Questions**

Pre-Webinar Questions

Please answer the questions below to measure the knowledge gained following the webinar and qualify for CME/CNE credit.

Which are the two most common amyloid subtypes that lead to cardiac amyloidosis?

The cardiac biomarker-based Mayo Staging system provides the following information:

Which of the following is the most important determinant of survival in patients with AL amyloidosis?

Select the correct statement regarding the pathophysiology of AL amyloidosis:

Which of the following is true regarding diagnostic delays in patients with AL amyloidosis?

The following finding should raise the suspicion of cardiac amyloidosis:

Patients with AL amyloidosis can present with the following signs and symptoms:

Diagnostic criteria of AL amyloidosis include:

Choose the correct criteria for cardiac response to treatment in AL amyloidosis

10.

Which of the following statement is true regarding hematologic response to treatment in AL amyloidosis?

11.

What statement is true regarding the management of patients with AL amyloidosis?

12.

Goals of treatment include:

Send me a copy of my responses